GL1X · GenesisL1 explorer

MolNFT v1 · #98378 · protein

Human ARTD3 (PARP3) - catalytic domain in complex with inhibitor ME0400

4L7R · Poly [ADP-ribose] polymerase 3: “Human ARTD3 (PARP3) - catalytic domain in complex with inhibitor ME0400”. X-ray diffraction, 1 ligand (M00), 2 pockets (best druggability 0.75). MolNFT v1 #98378 on GenesisL1: 3D structure, binding…

PDB
4L7R
Type
protein
Length
353 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 3
EC
2.4.2.30
UniProt
Q9Y6F1
Ligands
M00
Pockets
2 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APoly [ADP-ribose] polymerase 3 (EC 2.4.2.30)protein35337% helix, 24% strandQ9Y6F1

Ligands and binding sites

  • M00 · N-[(2S)-1-hydroxybutan-2-yl]-3-(4-oxo-3,4-dihydroquinazolin-2-yl)propanamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14870.750.8346M00
2690.330.7518empty

Compared structures

  • 4L7R · Human artd3 (parp3) - catalytic domain in complex with inhibitor ME0400 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9Y6F1 · AlphaFold monomer V2.0 prediction for protein mono-ADP- ribosyltransferase PARP3 (Q9Y6F1) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.